Samarth Kulkarni insider trades
Open-market stock purchases and sales by Samarth Kulkarni, Chief Executive Officer at CRISPR Therapeutics AG, from SEC Form 4 filings since Apr 19, 2017.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 19, 2026 | CRSP CRISPR Therapeutics AG | Sold | $2.4M |
| Oct 16, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Oct 16, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Oct 14, 2026 | CRSP CRISPR Therapeutics AG | Sold | $202K |
| Oct 13, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Oct 13, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Jun 26, 2026 | BDTX Black Diamond Therapeutics, Inc | Bought (not open market) | — |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Sold (not open market) | $1.2M |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Sold (not open market) | $497K |
| Jun 24, 2026 | CNTA Centessa Pharmaceuticals plc | Sold (not open market) | $427K |
| Jun 2, 2026 | ORKA Oruka Therapeutics, Inc | Bought (not open market) | — |
| Mar 23, 2026 | CRSP CRISPR Therapeutics AG | Sold | $469K |
| Mar 20, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Mar 20, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Mar 20, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Mar 16, 2026 | CRSP CRISPR Therapeutics AG | Sold | $499K |
| Mar 14, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Mar 11, 2026 | CRSP CRISPR Therapeutics AG | Sold | $517K |
| Mar 10, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Feb 19, 2026 | CRSP CRISPR Therapeutics AG | Sold | $366K |
| Feb 18, 2026 | CRSP CRISPR Therapeutics AG | Bought (not open market) | — |
| Jan 22, 2026 | CRSP CRISPR Therapeutics AG | Sold | $3.6M |
| Jan 20, 2026 | CRSP CRISPR Therapeutics AG | Sold | $1.1M |
| Jan 20, 2026 | CRSP CRISPR Therapeutics AG | Sold | $446K |
| Dec 18, 2025 | CRSP CRISPR Therapeutics AG | Sold (not open market) | — |
Companies traded
- CRSP CRISPR Therapeutics AG: 108 sales, last Oct 19, 2026
- BDTX Black Diamond Therapeutics, Inc: other filings, last Jun 26, 2026
- CNTA Centessa Pharmaceuticals plc: other filings, last Jun 24, 2026
- ORKA Oruka Therapeutics, Inc: other filings, last Jun 2, 2026
- RPTX Repare Therapeutics Inc: other filings, last Jun 17, 2024